Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SEOUL - Finance Minister Choi Sang-mok on Dec 27 became South Korea’s second acting president in two weeks, as lawmakers voted to impeach the current acting leader, Prime Minister Han Duck-soo ...

Finance Minister Choi becomes second acting president in weeks Choi has pledged unlimited liquidity to calm financial markets Veteran economic technocrat spent over 30 years in ministry SEOUL, Dec 27 ...

South Korea faces a historic first as Deputy Prime Minister and Finance Minister Choi Sang-mok assumes the role of acting president following the impeachment of acting President Han Duck-soo.

Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster results from a late-stage clinical trial. But far from being a reason to ...

Vertex Pharmaceuticals is trying to diversify its product portfolio. One of the programs it's working on aims to treat pain in a few contexts. There's reason to believe that it won't be effective ...

Choi Woo-seok is a new addition to the Squid Game season 2 roster who helps Seong Gi-hun investigate the games from the outside. Initially an indifferent contractor, Woo-seok takes a personal ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other stocks that will make you rich in 2025. Jurrien Timmer, Director of ...

H.C. Wainwright has recently reiterated Vertex Pharmaceuticals Inc (VRTX) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 19, 2024, Oppenheimer had ...

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $408.18, moving +0.72% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 1.1%.

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) Senores Pharmaceuticals IPO closes ...